Financial results - BIOSPECTRUM S.R.L.

Financial Summary - Biospectrum S.r.l.
Unique identification code: 13160011
Registration number: J40/6137/2000
Nace: 4773
Sales - Ron
263.461
Net Profit - Ron
1.179
Employees
1
Open Account
Company Biospectrum S.r.l. with Fiscal Code 13160011 recorded a turnover of 2024 of 263.461, with a net profit of 1.179 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Biospectrum S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 588.768 555.678 - 442.686 384.122 396.932 301.324 226.064 231.936 263.461
Total Income - EUR 588.804 555.919 - 442.695 384.151 397.360 304.370 226.346 231.939 263.766
Total Expenses - EUR 559.780 501.934 - 419.335 363.755 374.675 286.434 218.133 224.865 259.281
Gross Profit/Loss - EUR 29.023 53.986 - 23.360 20.395 22.685 17.936 8.213 7.073 4.485
Net Profit/Loss - EUR 23.426 45.144 - 18.933 16.554 18.711 14.987 5.798 4.754 1.179
Employees 4 3 - 3 3 4 2 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 14.2%, from 231.936 euro in the year 2023, to 263.461 euro in 2024. The Net Profit decreased by -3.549 euro, from 4.754 euro in 2023, to 1.179 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Biospectrum S.r.l.

Rating financiar

Financial Rating -
BIOSPECTRUM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Biospectrum S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biospectrum S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Biospectrum S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biospectrum S.r.l. - CUI 13160011

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 1.089 8.965 - 3.289 2.380 21.939 16.901 15.295 12.081 27.237
Current Assets 430.890 401.072 - 316.741 281.249 263.353 254.218 216.655 197.039 206.861
Inventories 204.219 243.542 - 190.702 185.113 178.682 176.801 189.892 158.187 147.779
Receivables 65.138 81.849 - 94.258 68.977 70.242 54.216 21.703 34.004 47.188
Cash 161.533 75.680 - 31.781 27.159 14.429 23.201 5.061 4.848 11.895
Shareholders Funds 232.621 45.205 - 82.773 97.723 114.581 169.919 139.919 150.929 87.228
Social Capital 45 45 - 43 42 41 40 41 40 40
Debts 199.358 364.832 - 237.257 188.190 170.712 101.200 92.032 58.191 152.340
Income in Advance 0 0 - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 206.861 euro in 2024 which includes Inventories of 147.779 euro, Receivables of 47.188 euro and cash availability of 11.895 euro.
The company's Equity was valued at 87.228 euro, while total Liabilities amounted to 152.340 euro. Equity decreased by -62.857 euro, from 150.929 euro in 2023, to 87.228 in 2024.

Risk Reports Prices

Reviews - Biospectrum S.r.l.

Comments - Biospectrum S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.